Predict your next investment

INTERNET | Internet Software & Services / Travel
kds.com

See what CB Insights has to offer

Founded Year

1994

Stage

Acquired | Acquired

About Kds

KDS is a global provider of integrated travel technology and complete door-to-door trip booking.

Kds Headquarter Location

Centre d'affaires La Boursidiere BP 160

Paris, 92357,

France

Latest Kds News

Kiadis Announces Results of Annual General Meeting of Shareholders

Jun 25, 2020

| Source: Kiadis Pharma N.V. Amsterdam, The Netherlands, June 25, 2020 – Kiadis Pharma N.V. (“Kiadis” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, announces that at its Annual General Meeting held today at 10:00 CEST, all resolutions were duly passed by the shareholders. About Kiadis Founded in 1997, Kiadis is building a fully integrated biopharmaceutical company committed to developing innovative therapies for patients with life-threatening diseases. With headquarters in Amsterdam, the Netherlands, and offices and activities across the United States, Kiadis is reimagining medicine by leveraging the natural strengths of humanity and our collective immune system to source the best cells for life. Kiadis is listed on the regulated market of Euronext Amsterdam and Euronext Brussels since July 2, 2015, under the symbol KDS. Learn more at www.kiadis.com . Kiadis Contacts: Dutch Translation/Nederlandse vertaling Amsterdam, Nederland, 25 juni 2020 – Kiadis Pharma nv ('Kiadis' of de 'vennootschap') (Euronext Amsterdam en Brussel: KDS), een biofarmaceutisch bedrijf gericht op onderzoek in de klinische fase, kondigt aan dat alle resoluties op de jaarlijkse algemene vergadering, die vandaag werd gehouden om 10.00 uur CEST, werden ondersteund door de aandeelhouders. Dit persbericht vormt een vertaling van het gepubliceerde Engelstalige persbericht. Bij eventuele verschillen is de tekst van het Engelstalige persbericht altijd bepalend. Forward Looking Statements Certain statements, beliefs and opinions in this press release are forward-looking, which reflect Kiadis’ or, as appropriate, Kiadis’ officers’ current expectations and projections about future events. By their nature, forward-looking statements involve a number of known and unknown risks, uncertainties and assumptions that could cause actual results, performance, achievements or events to differ materially from those expressed, anticipated or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, regulation, competition and technology, can cause actual events, performance, achievements or results to differ significantly from any anticipated or implied development. Forward-looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, Kiadis expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or projections, or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based. Neither Kiadis nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the anticipated or implied developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release. Related Articles

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kds

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kds is included in 3 Expert Collections, including Smart Money VCs (2017-2019).

S

Smart Money VCs (2017-2019)

6,297 items

We crunched the data to identify the 24 VC firms with the best combination of portfolio valuations and investment outcomes.

T

Travel Technology (Travel Tech)

2,046 items

The travel tech collection includes companies offering tech-enabled services and products for tourists and travel players (hotels, airlines, airports, cruises, etc.). It excludes financial services and micro-mobility solutions.

F

Fintech

10,749 items

Excludes US-based companies

Kds Patents

Kds has filed 7 patents.

The 3 most popular patent topics include:

  • Acrylate esters
  • Acrylate polymers
  • Aerodynamics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/22/2017

1/8/2019

Posttranslational modification, Fluid dynamics, Power forwards (basketball), Small forwards, Aerodynamics

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/22/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

1/8/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Posttranslational modification, Fluid dynamics, Power forwards (basketball), Small forwards, Aerodynamics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.